Will Arista Networks (ANET) Beat Estimates Again in Its Next Earnings Report? — Positive
ANET Zacks Investment Research — October 07, 2025Arista Networks (ANET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Ralph Lauren (RL) Beat Estimates Again in Its Next Earnings Report? — Positive
RL Zacks Investment Research — October 07, 2025Ralph Lauren (RL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why T. Rowe (TROW) is Poised to Beat Earnings Estimates Again — Positive
TROW Zacks Investment Research — October 07, 2025T. Rowe (TROW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why United (UAL) Could Beat Earnings Estimates Again — Positive
UAL Zacks Investment Research — October 07, 2025United (UAL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will MSCI (MSCI) Beat Estimates Again in Its Next Earnings Report? — Positive
MSCI Zacks Investment Research — October 07, 2025MSCI (MSCI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Fair Isaac (FICO) is Poised to Beat Earnings Estimates Again — Positive
FICO Zacks Investment Research — October 07, 2025Fair Isaac (FICO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report? — Positive
INCY Zacks Investment Research — October 07, 2025Incyte (INCY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? — Positive
ILMN Zacks Investment Research — October 07, 2025Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Monster Beverage (MNST) is Poised to Beat Earnings Estimates Again — Positive
MNST Zacks Investment Research — October 07, 2025Monster Beverage (MNST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Capital One (COF) is Poised to Beat Earnings Estimates Again — Positive
COF Zacks Investment Research — October 07, 2025Capital One (COF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Palomar (PLMR) Beat Estimates Again in Its Next Earnings Report? — Positive
PLMR Zacks Investment Research — October 07, 2025Palomar (PLMR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Alphabet's stock could soar as Google's Gemini AI gets a TikTok-style makeover — Positive
GOOG GOOGL Market Watch — October 07, 2025A potential redesign of Gemini could boost user engagement and serve as the next catalyst for Alphabet's already-hot stock.

Is Robinhood's Dominance at Stake as GLXY Enters Retail Investing? — Neutral
HOOD Zacks Investment Research — October 07, 2025Galaxy Digital's GalaxyOne app enters retail investing with high-yield cash accounts, posing a new challenge to Robinhood's market lead.

3 Stocks to Buy From the Prospering Leisure & Recreation Industry — Positive
GOLF MODG PTON Zacks Investment Research — October 07, 2025The Leisure and Recreation Products industry is benefiting from strong fitness demand and booming golf trends. Moreover, stocks like GOLF, PTON and MODG are likely to benefit from the trend.

Can WBD's Studio Business Emerge as the Core Engine of EBITDA Growth? — Positive
WBD Zacks Investment Research — October 07, 2025With fresh creative energy and a global content strategy, WBD's Studio arm is shaping into the company's long-term growth driver.

Tetra Technologies (TTI) Moves 5.2% Higher: Will This Strength Last? — Positive
TTI Zacks Investment Research — October 07, 2025Tetra Technologies (TTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

ROSEN, THE FIRST FILING FIRM, Encourages KBR, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KBR — Neutral
KBR GlobeNewsWire — October 07, 2025NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

On Tuesday, CoinShares expanded its ETF lineup with the release of the CoinShares Altcoins ETF (DIME). DIME seeks to generate capital appreciation through a diversified portfolio of altcoins.

Oracle shares fall on report the company is struggling to make money renting out Nvidia chips — Negative
NVDA ORCL CNBC Television — October 07, 2025CNBC's Kristina Partsinevelos joins ‘Halftime Report' to discuss the latest from a report that Oracle is struggling to make money renting out Nvidia Chips.

MRK Expands Tulisokibart Program in Three New Inflammatory Diseases — Positive
MRK Zacks Investment Research — October 07, 2025Merck broadens its tulisokibart clinical program with three new phase IIb studies, deepening its reach across immune-mediated inflammatory diseases.
